カテゴリ： 世界, 医療/バイオ, QYResearch

セービン不活化ポリオワクチン（sIPV）の世界市場2023年：バイアル、シリンジ

■ 英語タイトル：Global Sabin Inactivated Polio vaccine (sIPV) Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8345）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8345
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：86
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥429,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥643,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥858,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[セービン不活化ポリオワクチン（sIPV）の世界市場2023年：バイアル、シリンジ]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はセービン不活化ポリオワクチン（sIPV）のグローバル市場について調査・分析し、世界のセービン不活化ポリオワクチン（sIPV）市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（バイアル、シリンジ）、用途別セグメント分析（病院、クリニック、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Biokangtai、Sinovac、Imbcams、Intravacc、Beijing Biologicalなどが含まれています。セービン不活化ポリオワクチン（sIPV）のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、セービン不活化ポリオワクチン（sIPV）市場規模を算出する際に考慮しました。

・セービン不活化ポリオワクチン（sIPV）市場の概要
- 製品の定義
- セービン不活化ポリオワクチン（sIPV）の種類別セグメント
- 世界のセービン不活化ポリオワクチン（sIPV）市場規模：タイプ別分析（バイアル、シリンジ）
- セービン不活化ポリオワクチン（sIPV）の用途別セグメント
- 世界のセービン不活化ポリオワクチン（sIPV）市場規模：用途別分析（病院、クリニック、その他）
- 世界のセービン不活化ポリオワクチン（sIPV）市場規模予測（2018年-2029年）
- セービン不活化ポリオワクチン（sIPV）の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- セービン不活化ポリオワクチン（sIPV）市場の競争状況およびトレンド

・セービン不活化ポリオワクチン（sIPV）の地域別市場規模
- 北米のセービン不活化ポリオワクチン（sIPV）市場規模（2018年-2029年）
- 米国のセービン不活化ポリオワクチン（sIPV）市場規模（2018年-2029年）
- ヨーロッパのセービン不活化ポリオワクチン（sIPV）市場規模（2018年-2029年）
- アジア太平洋のセービン不活化ポリオワクチン（sIPV）市場規模（2018年-2029年）
- 中国のセービン不活化ポリオワクチン（sIPV）市場規模（2018年-2029年）
- 日本のセービン不活化ポリオワクチン（sIPV）市場規模（2018年-2029年）
- 韓国のセービン不活化ポリオワクチン（sIPV）市場規模（2018年-2029年）
- インドのセービン不活化ポリオワクチン（sIPV）市場規模（2018年-2029年）
- オーストラリアのセービン不活化ポリオワクチン（sIPV）市場規模（2018年-2029年）
- 中南米のセービン不活化ポリオワクチン（sIPV）市場規模（2018年-2029年）
- 中東・アフリカのセービン不活化ポリオワクチン（sIPV）市場規模（2018年-2029年）

・種類別セグメント：バイアル、シリンジ
- 世界のセービン不活化ポリオワクチン（sIPV）のタイプ別販売量（2018年-2023年）
- 世界のセービン不活化ポリオワクチン（sIPV）のタイプ別売上（2018年-2023年）
- 世界のセービン不活化ポリオワクチン（sIPV）のタイプ別価格

・用途別セグメント：病院、クリニック、その他
- 世界のセービン不活化ポリオワクチン（sIPV）の用途別販売量（2018年-2023年）
- 世界のセービン不活化ポリオワクチン（sIPV）の用途別売上（2018年-2023年）
- 世界のセービン不活化ポリオワクチン（sIPV）の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Biokangtai、Sinovac、Imbcams、Intravacc、Beijing Biological

・産業チェーンと販売チャネルの分析
- セービン不活化ポリオワクチン（sIPV）産業チェーン分析
- セービン不活化ポリオワクチン（sIPV）の主要原材料
- セービン不活化ポリオワクチン（sIPV）の販売チャネル
- セービン不活化ポリオワクチン（sIPV）のディストリビューター
- セービン不活化ポリオワクチン（sIPV）の主要顧客

・セービン不活化ポリオワクチン（sIPV）市場ダイナミクス
- セービン不活化ポリオワクチン（sIPV）の業界動向
- セービン不活化ポリオワクチン（sIPV）市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Sabin Inactivated Polio vaccine (sIPV) market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Sabin Inactivated Polio vaccine (sIPV) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Sabin Inactivated Polio vaccine (sIPV) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Sabin Inactivated Polio vaccine (sIPV) include Biokangtai, Sinovac, Imbcams, Intravacc and Beijing Biological, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sabin Inactivated Polio vaccine (sIPV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sabin Inactivated Polio vaccine (sIPV).
The Sabin Inactivated Polio vaccine (sIPV) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Sabin Inactivated Polio vaccine (sIPV) market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sabin Inactivated Polio vaccine (sIPV) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Biokangtai
Sinovac
Imbcams
Intravacc
Beijing Biological
Segment by Type
Vials
Syringes
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sabin Inactivated Polio vaccine (sIPV) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sabin Inactivated Polio vaccine (sIPV) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Sabin Inactivated Polio vaccine (sIPV) Market Overview
1.1 Product Overview and Scope of Sabin Inactivated Polio vaccine (sIPV)
1.2 Sabin Inactivated Polio vaccine (sIPV) Segment by Type
1.2.1 Global Sabin Inactivated Polio vaccine (sIPV) Market Value Comparison by Type (2023-2029)
1.2.2 Vials
1.2.3 Syringes
1.3 Sabin Inactivated Polio vaccine (sIPV) Segment by Application
1.3.1 Global Sabin Inactivated Polio vaccine (sIPV) Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Sabin Inactivated Polio vaccine (sIPV) Market Size Estimates and Forecasts
1.4.1 Global Sabin Inactivated Polio vaccine (sIPV) Revenue 2018-2029
1.4.2 Global Sabin Inactivated Polio vaccine (sIPV) Sales 2018-2029
1.4.3 Global Sabin Inactivated Polio vaccine (sIPV) Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Sabin Inactivated Polio vaccine (sIPV) Market Competition by Manufacturers
2.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Manufacturers (2018-2023)
2.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Sabin Inactivated Polio vaccine (sIPV) Average Price by Manufacturers (2018-2023)
2.4 Global Sabin Inactivated Polio vaccine (sIPV) Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Sabin Inactivated Polio vaccine (sIPV), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sabin Inactivated Polio vaccine (sIPV), Product Type & Application
2.7 Sabin Inactivated Polio vaccine (sIPV) Market Competitive Situation and Trends
2.7.1 Sabin Inactivated Polio vaccine (sIPV) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sabin Inactivated Polio vaccine (sIPV) Players Market Share by Revenue
2.7.3 Global Sabin Inactivated Polio vaccine (sIPV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sabin Inactivated Polio vaccine (sIPV) Retrospective Market Scenario by Region
3.1 Global Sabin Inactivated Polio vaccine (sIPV) Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Sabin Inactivated Polio vaccine (sIPV) Global Sabin Inactivated Polio vaccine (sIPV) Sales by Region: 2018-2029
3.2.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales by Region: 2018-2023
3.2.2 Global Sabin Inactivated Polio vaccine (sIPV) Sales by Region: 2024-2029
3.3 Global Sabin Inactivated Polio vaccine (sIPV) Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Region: 2018-2029
3.3.1 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Region: 2018-2023
3.3.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Region: 2024-2029
3.4 North America Sabin Inactivated Polio vaccine (sIPV) Market Facts & Figures by Country
3.4.1 North America Sabin Inactivated Polio vaccine (sIPV) Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2018-2029)
3.4.3 North America Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sabin Inactivated Polio vaccine (sIPV) Market Facts & Figures by Country
3.5.1 Europe Sabin Inactivated Polio vaccine (sIPV) Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2018-2029)
3.5.3 Europe Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Market Facts & Figures by Country
3.6.1 Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2018-2029)
3.6.3 Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Sabin Inactivated Polio vaccine (sIPV) Market Facts & Figures by Country
3.7.1 Latin America Sabin Inactivated Polio vaccine (sIPV) Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2018-2029)
3.7.3 Latin America Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sabin Inactivated Polio vaccine (sIPV) Market Facts & Figures by Country
3.8.1 Middle East and Africa Sabin Inactivated Polio vaccine (sIPV) Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2018-2029)
3.8.3 Middle East and Africa Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2018-2029)
4.1.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2018-2023)
4.1.2 Global Sabin Inactivated Polio vaccine (sIPV) Sales by Type (2024-2029)
4.1.3 Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Type (2018-2029)
4.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Type (2018-2029)
4.2.1 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Type (2018-2023)
4.2.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Type (2024-2029)
4.2.3 Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Type (2018-2029)
4.3 Global Sabin Inactivated Polio vaccine (sIPV) Price by Type (2018-2029)
5 Segment by Application
5.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2018-2029)
5.1.1 Global Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2018-2023)
5.1.2 Global Sabin Inactivated Polio vaccine (sIPV) Sales by Application (2024-2029)
5.1.3 Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Application (2018-2029)
5.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Application (2018-2029)
5.2.1 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Application (2018-2023)
5.2.2 Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Application (2024-2029)
5.2.3 Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Application (2018-2029)
5.3 Global Sabin Inactivated Polio vaccine (sIPV) Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Biokangtai
6.1.1 Biokangtai Corporation Information
6.1.2 Biokangtai Description and Business Overview
6.1.3 Biokangtai Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Biokangtai Sabin Inactivated Polio vaccine (sIPV) Product Portfolio
6.1.5 Biokangtai Recent Developments/Updates
6.2 Sinovac
6.2.1 Sinovac Corporation Information
6.2.2 Sinovac Description and Business Overview
6.2.3 Sinovac Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sinovac Sabin Inactivated Polio vaccine (sIPV) Product Portfolio
6.2.5 Sinovac Recent Developments/Updates
6.3 Imbcams
6.3.1 Imbcams Corporation Information
6.3.2 Imbcams Description and Business Overview
6.3.3 Imbcams Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Imbcams Sabin Inactivated Polio vaccine (sIPV) Product Portfolio
6.3.5 Imbcams Recent Developments/Updates
6.4 Intravacc
6.4.1 Intravacc Corporation Information
6.4.2 Intravacc Description and Business Overview
6.4.3 Intravacc Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Intravacc Sabin Inactivated Polio vaccine (sIPV) Product Portfolio
6.4.5 Intravacc Recent Developments/Updates
6.5 Beijing Biological
6.5.1 Beijing Biological Corporation Information
6.5.2 Beijing Biological Description and Business Overview
6.5.3 Beijing Biological Sabin Inactivated Polio vaccine (sIPV) Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Beijing Biological Sabin Inactivated Polio vaccine (sIPV) Product Portfolio
6.5.5 Beijing Biological Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sabin Inactivated Polio vaccine (sIPV) Industry Chain Analysis
7.2 Sabin Inactivated Polio vaccine (sIPV) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sabin Inactivated Polio vaccine (sIPV) Production Mode & Process
7.4 Sabin Inactivated Polio vaccine (sIPV) Sales and Marketing
7.4.1 Sabin Inactivated Polio vaccine (sIPV) Sales Channels
7.4.2 Sabin Inactivated Polio vaccine (sIPV) Distributors
7.5 Sabin Inactivated Polio vaccine (sIPV) Customers
8 Sabin Inactivated Polio vaccine (sIPV) Market Dynamics
8.1 Sabin Inactivated Polio vaccine (sIPV) Industry Trends
8.2 Sabin Inactivated Polio vaccine (sIPV) Market Drivers
8.3 Sabin Inactivated Polio vaccine (sIPV) Market Challenges
8.4 Sabin Inactivated Polio vaccine (sIPV) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Sabin Inactivated Polio vaccine (sIPV) Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Sabin Inactivated Polio vaccine (sIPV) Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Sabin Inactivated Polio vaccine (sIPV) Market Competitive Situation by Manufacturers in 2022
Table 4. Global Sabin Inactivated Polio vaccine (sIPV) Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Sabin Inactivated Polio vaccine (sIPV) Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Sabin Inactivated Polio vaccine (sIPV) Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Sabin Inactivated Polio vaccine (sIPV), Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Sabin Inactivated Polio vaccine (sIPV), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Sabin Inactivated Polio vaccine (sIPV), Product Type & Application
Table 12. Global Key Manufacturers of Sabin Inactivated Polio vaccine (sIPV), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sabin Inactivated Polio vaccine (sIPV) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sabin Inactivated Polio vaccine (sIPV) as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Sabin Inactivated Polio vaccine (sIPV) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Sabin Inactivated Polio vaccine (sIPV) Sales by Region (2018-2023) & (K Units)
Table 18. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Region (2018-2023)
Table 19. Global Sabin Inactivated Polio vaccine (sIPV) Sales by Region (2024-2029) & (K Units)
Table 20. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Region (2024-2029)
Table 21. Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Region (2018-2023)
Table 23. Global Sabin Inactivated Polio vaccine (sIPV) Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Region (2024-2029)
Table 25. North America Sabin Inactivated Polio vaccine (sIPV) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2018-2023) & (K Units)
Table 27. North America Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2024-2029) & (K Units)
Table 28. North America Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Sabin Inactivated Polio vaccine (sIPV) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2018-2023) & (K Units)
Table 32. Europe Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2024-2029) & (K Units)
Table 33. Europe Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Sabin Inactivated Polio vaccine (sIPV) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Sabin Inactivated Polio vaccine (sIPV) Sales (K Units) by Type (2018-2023)
Table 51. Global Sabin Inactivated Polio vaccine (sIPV) Sales (K Units) by Type (2024-2029)
Table 52. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Type (2018-2023)
Table 53. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Type (2024-2029)
Table 54. Global Sabin Inactivated Polio vaccine (sIPV) Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Sabin Inactivated Polio vaccine (sIPV) Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Type (2018-2023)
Table 57. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Type (2024-2029)
Table 58. Global Sabin Inactivated Polio vaccine (sIPV) Price (US$/Unit) by Type (2018-2023)
Table 59. Global Sabin Inactivated Polio vaccine (sIPV) Price (US$/Unit) by Type (2024-2029)
Table 60. Global Sabin Inactivated Polio vaccine (sIPV) Sales (K Units) by Application (2018-2023)
Table 61. Global Sabin Inactivated Polio vaccine (sIPV) Sales (K Units) by Application (2024-2029)
Table 62. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Application (2018-2023)
Table 63. Global Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Application (2024-2029)
Table 64. Global Sabin Inactivated Polio vaccine (sIPV) Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Sabin Inactivated Polio vaccine (sIPV) Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Application (2018-2023)
Table 67. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Application (2024-2029)
Table 68. Global Sabin Inactivated Polio vaccine (sIPV) Price (US$/Unit) by Application (2018-2023)
Table 69. Global Sabin Inactivated Polio vaccine (sIPV) Price (US$/Unit) by Application (2024-2029)
Table 70. Biokangtai Corporation Information
Table 71. Biokangtai Description and Business Overview
Table 72. Biokangtai Sabin Inactivated Polio vaccine (sIPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Biokangtai Sabin Inactivated Polio vaccine (sIPV) Product
Table 74. Biokangtai Recent Developments/Updates
Table 75. Sinovac Corporation Information
Table 76. Sinovac Description and Business Overview
Table 77. Sinovac Sabin Inactivated Polio vaccine (sIPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Sinovac Sabin Inactivated Polio vaccine (sIPV) Product
Table 79. Sinovac Recent Developments/Updates
Table 80. Imbcams Corporation Information
Table 81. Imbcams Description and Business Overview
Table 82. Imbcams Sabin Inactivated Polio vaccine (sIPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Imbcams Sabin Inactivated Polio vaccine (sIPV) Product
Table 84. Imbcams Recent Developments/Updates
Table 85. Intravacc Corporation Information
Table 86. Intravacc Description and Business Overview
Table 87. Intravacc Sabin Inactivated Polio vaccine (sIPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Intravacc Sabin Inactivated Polio vaccine (sIPV) Product
Table 89. Intravacc Recent Developments/Updates
Table 90. Beijing Biological Corporation Information
Table 91. Beijing Biological Description and Business Overview
Table 92. Beijing Biological Sabin Inactivated Polio vaccine (sIPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Beijing Biological Sabin Inactivated Polio vaccine (sIPV) Product
Table 94. Beijing Biological Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Sabin Inactivated Polio vaccine (sIPV) Distributors List
Table 98. Sabin Inactivated Polio vaccine (sIPV) Customers List
Table 99. Sabin Inactivated Polio vaccine (sIPV) Market Trends
Table 100. Sabin Inactivated Polio vaccine (sIPV) Market Drivers
Table 101. Sabin Inactivated Polio vaccine (sIPV) Market Challenges
Table 102. Sabin Inactivated Polio vaccine (sIPV) Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Sabin Inactivated Polio vaccine (sIPV)
Figure 2. Global Sabin Inactivated Polio vaccine (sIPV) Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Sabin Inactivated Polio vaccine (sIPV) Market Share by Type in 2022 & 2029
Figure 4. Vials Product Picture
Figure 5. Syringes Product Picture
Figure 6. Global Sabin Inactivated Polio vaccine (sIPV) Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Sabin Inactivated Polio vaccine (sIPV) Market Share by Application in 2022 & 2029
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Global Sabin Inactivated Polio vaccine (sIPV) Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Sabin Inactivated Polio vaccine (sIPV) Market Size (2018-2029) & (US$ Million)
Figure 13. Global Sabin Inactivated Polio vaccine (sIPV) Sales (2018-2029) & (K Units)
Figure 14. Global Sabin Inactivated Polio vaccine (sIPV) Average Price (US$/Unit) & (2018-2029)
Figure 15. Sabin Inactivated Polio vaccine (sIPV) Report Years Considered
Figure 16. Sabin Inactivated Polio vaccine (sIPV) Sales Share by Manufacturers in 2022
Figure 17. Global Sabin Inactivated Polio vaccine (sIPV) Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Sabin Inactivated Polio vaccine (sIPV) Players: Market Share by Revenue in 2022
Figure 19. Sabin Inactivated Polio vaccine (sIPV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Sabin Inactivated Polio vaccine (sIPV) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Country (2018-2029)
Figure 22. North America Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Country (2018-2029)
Figure 23. U.S. Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Country (2018-2029)
Figure 26. Europe Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Country (2018-2029)
Figure 27. Germany Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Region (2018-2029)
Figure 34. China Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Taiwan Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Philippines Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Country (2018-2029)
Figure 45. Latin America Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Sabin Inactivated Polio vaccine (sIPV) Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. U.A.E Sabin Inactivated Polio vaccine (sIPV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Sabin Inactivated Polio vaccine (sIPV) by Type (2018-2029)
Figure 55. Global Revenue Market Share of Sabin Inactivated Polio vaccine (sIPV) by Type (2018-2029)
Figure 56. Global Sabin Inactivated Polio vaccine (sIPV) Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Sabin Inactivated Polio vaccine (sIPV) by Application (2018-2029)
Figure 58. Global Revenue Market Share of Sabin Inactivated Polio vaccine (sIPV) by Application (2018-2029)
Figure 59. Global Sabin Inactivated Polio vaccine (sIPV) Price (US$/Unit) by Application (2018-2029)
Figure 60. Sabin Inactivated Polio vaccine (sIPV) Value Chain
Figure 61. Sabin Inactivated Polio vaccine (sIPV) Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • プロトロンビン複合体濃縮物（PCC）医薬品の世界市場2023年：500 IU/バイアル、600 IU/バイアル、1000 IU/バイアル、その他
  • チオテパ注射のグローバル市場展望 2023年-2029年：15mg/バイアル、100mg/バイアル
  • インフルエンザ菌b型混合ワクチンの世界市場2023年：バイアル、プレフィルド
  • 細胞培養系インフルエンザワクチンのグローバル市場展望 2023年-2029年：バイアル、充填済み
  • 13価肺炎球菌多糖体複合体ワクチンのグローバル市場展望 2023年-2029年：バイアル、充填済み
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8345 )"セービン不活化ポリオワクチン（sIPV）の世界市場2023年：バイアル、シリンジ" (英文：Global Sabin Inactivated Polio vaccine (sIPV) Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。